Gene Delivery of c-myb Increases Bone Formation Surrounding Oral Implants

Bone regeneration around titanium (Ti) implants is a relatively slow process. The c-myb transcription factor has been associated with high proliferation and differentiation rates in bone. This study analyzed whether c-myb can enhance new bone surrounding the implant. In vitro overexpressed chitosan-gold nanoparticles conjugated with plasmid DNA/c-myb (Ch-GNPs/c-myb)-coated Ti surfaces were associated with enhanced expression of the osteogenic molecules osteopontin (OPN), runt-related transcription factor 2 (RUNX-2), and bone morphogenetic proteins (BMP2/7) in MC-3T3E1 osteoblast cells. Further, to determine its in vivo effect, we inserted Ch-GNPs/c-myb-coated Ti implants into rat mandibles. One and 4 wks post-implantation, mandibles were examined by microcomputed tomography, immunohistochemistry, and hematoxylin & eosin staining. The microcomputed tomography analysis demonstrated that c-myb overexpression increased the density and volume of newly formed bone surrounding the implants, compared with those in controls (p < .05). Further, c-myb increased the number of cells expressing BMP2/7 and aided in the increase of new bone (p < .05). These results support the view that c-myb overexpression accelerates new bone surrounding implants and can serve as a potent molecule in promoting tissue regeneration around dental implants. The recipient rat used in this system provides an excellent in vivo model for studies of bone regeneration.

[1]  I. Park,et al.  PPARγ delivered by Ch-GNPs onto titanium surfaces inhibits implant-induced inflammation and induces bone mineralization of MC-3T3E1 osteoblast-like cells. , 2013, Clinical oral implants research.

[2]  Jie Yang,et al.  Alveolar ridge augmentation using implants coated with recombinant human growth/differentiation factor -5 (rhGDF-5). Radiographic observations. , 2012, Clinical oral implants research.

[3]  J. Šmarda,et al.  Localization of c-MYB in differentiated cells during postnatal molar and alveolar bone development. , 2012, European journal of oral sciences.

[4]  A. Ignatius,et al.  Nanoparticles and their potential for application in bone , 2012, International journal of nanomedicine.

[5]  G. Yuan,et al.  BMP Activity Is Required for Tooth Development from the Lamina to Bud Stage , 2012, Journal of dental research.

[6]  Wei Zhang,et al.  Enhanced bone regeneration around dental implant with bone morphogenetic protein 2 gene and vascular endothelial growth factor protein delivery. , 2012, Clinical oral implants research.

[7]  E. Luo,et al.  Enhanced osseointegration of titanium implant through the local delivery of transcription factor SATB2. , 2011, Biomaterials.

[8]  J. Šmarda,et al.  Expression and characterization of c‐Myb in prenatal odontogenesis , 2011, Development, growth & differentiation.

[9]  Q. Jin,et al.  Gene expression dynamics during bone healing and osseointegration. , 2011, Journal of periodontology.

[10]  Tu‐Lai Yew,et al.  Intramarrow bone morphogenetic protein 4 gene delivery improves local bone quality in femurs of ovariectomized rabbits. , 2011, Journal of periodontology.

[11]  Steven A. Goldstein,et al.  PDGF-B Gene Therapy Accelerates Bone Engineering and Oral Implant Osseointegration , 2009, Gene Therapy.

[12]  H. Yi,et al.  c-myb has a character of oxidative stress resistance in aged human diploid fibroblasts: regulates SAPK/JNK and Hsp60 pathway consequently , 2010, Biogerontology.

[13]  Y. Seol,et al.  Critical Reviews in Oral Biology & Medicine: Pre-clinical Models for Oral and Periodontal Reconstructive Therapies , 2009 .

[14]  P. Krebsbach,et al.  Osterix Enhances BMSC-associated Osseointegration of Implants , 2009, Journal of dental research.

[15]  Robert G. Ramsay,et al.  MYB function in normal and cancer cells , 2008, Nature Reviews Cancer.

[16]  Lonnie D Shea,et al.  Matrices and scaffolds for DNA delivery in tissue engineering. , 2007, Advanced drug delivery reviews.

[17]  L. Greene,et al.  Cell cycle molecules define a pathway required for neuron death in development and disease. , 2007, Biochimica et biophysica acta.

[18]  C. Helgason,et al.  Identification of novel genes and transcription factors involved in spleen, thymus and immunological development and function , 2006, Genes and Immunity.

[19]  G. Schmidmaier,et al.  Locally delivered TGF-β1 and IGF-1 enhance the fixation of titanium implants: A study in dogs , 2006, Acta orthopaedica.

[20]  P. Delmas,et al.  The role of collagen in bone strength , 2005, Osteoporosis International.

[21]  R. Franceschi,et al.  Biological Approaches to Bone Regeneration by Gene Therapy , 2005, Journal of dental research.

[22]  C. A. Dunn,et al.  BMP gene delivery for alveolar bone engineering at dental implant defects. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[23]  W. Saltzman,et al.  Surface-mediated gene transfer from nanocomposites of controlled texture , 2004, Nature materials.

[24]  S. K. Zaidi,et al.  Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors. , 2004, Critical reviews in eukaryotic gene expression.

[25]  D. Puleo,et al.  Understanding and controlling the bone-implant interface. , 1999, Biomaterials.

[26]  E. Reddy,et al.  The myb gene family in cell growth, differentiation and apoptosis , 1999, Oncogene.

[27]  A. Gabrielli,et al.  C-myb, but not B-myb, upregulates type I collagen gene expression in human fibroblasts. , 1999, The Journal of investigative dermatology.

[28]  B. Aronow,et al.  Diverse developing mouse lineages exhibit high-level c-Myb expression in immature cells and loss of expression upon differentiation , 1999, Oncogene.

[29]  N. Karimbux,et al.  A new animal model for molecular biological analysis of the implant-tissue interface: spatial expression of type XII collagen mRNA around a titanium oral implant. , 1995, The Journal of oral implantology.

[30]  S. Swerdlow,et al.  A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis , 1991, Cell.